Delivery Order SPE2DR25D3009-SPE2DR26FWHD6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls with a ceiling value of $5,173.87. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of January 9, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $27,920.22 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL pharmaceutical supplies. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and was awarded on January 2, 2026. This award was made through open competition with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,108.54 to AmerisourceBergen Drug Corp for the supply of Humira Pen 40 mg/0.8 mL on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,662.84 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product for treating inflammatory conditions. This competitively awarded, firm fixed-price delivery order was issued on November 4, 2025, with an ultimate completion date of November 5, 2025. The contract involves no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,065.58 to AmerisourceBergen Drug Corp for the supply of HUMIRA(CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on January 5, 2026, with an ultimate completion date of January 6, 2026, and will be performed at the contractor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,785.93 by the Defense Logistics Agency (DLA) for HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of January 2, 2026. This competitively awarded, firm fixed-price delivery order is not designated as a set-aside contract and represents a continuation of the company's critical role in supplying pharmaceutical products to...
- The Defense Logistics Agency awarded a $2,387.94 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal medical procurement needs. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $4,477.18 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is executed under a child contract arrangement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,742.35 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls on January 5, 2026, with completion anticipated by January 6, 2026. This competitive award utilizing firm fixed pricing represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,989.95 to AmerisourceBergen Drug Corp for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an open contracting process. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWHD6Delivery Order
The Defense Logistics Agency (DLA) awarded a $62,044.86 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, with an ultimate completion date of January 8, 2026. The contract was competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. Performance will take place at the awardee's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 through December 2026. This comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, vaccines, and other critical medical commodities. The contract demonstrates AmerisourceBergen's ongoing role as a primary pharmaceutical supplier for the Defense Health Agency and other federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $62.0k | 1/6/26 |